BIO-key, Provider of Identity and Access Management Solutions with Enhanced Biometrics, Hosts Q2 Investor Call Wed. Aug. 13th at 10am ET

Rhea-AI Summary

BIO-key International (NASDAQ: BKYI), a provider of Identity and Access Management solutions with biometric authentication capabilities, has scheduled its Q2 2025 earnings conference call for Wednesday, August 13th at 10:00 AM ET. The company will release its financial results before market open on the same day.

The call will be led by Chairman & CEO Mike DePasquale and CFO Cecilia Welch, featuring a Q&A session. Investors can access the call via U.S. dial-in (1-877-418-5460) or international dial-in (1-412-717-9594), with webcast replay available for 3 months.

News Market Reaction

-2.23%

2 alerts

-2.23% News Effect

-$117K Valuation Impact

$5M Market Cap

0.0x Rel. Volume

On the day this news was published, BKYI declined 2.23%, reflecting a moderate negative market reaction. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $117K from the company's valuation, bringing the market cap to $5M at that time.

Data tracked by StockTitan Argus on the day of publication.

HOLMDEL, N.J., Aug. 05, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management solutions featuring passwordless, phoneless, and tokenless Identity-Bound Biometric authentication, will host its second quarter 2025 investor call on Wednesday, August 13th at 10 a.m. ET. Results will be released before the stock market opens that morning. Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will lead the conference call and host a Q&A session.

Call Details
Date / Time: Call Dial In #: Live Webcast / Replay: Audio Replay:	Wednesday, August 13th at 10 a.m. ET 1-877-418-5460 U.S. or 1-412-717-9594 Int’l Webcast & Replay Link – Available for 3 months. 1-877-344-7529 U.S. or 1-412-317-0088 Int’l; code 8281392

About BIO-key International, Inc. (www.BIO-key.com)

BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.

Engage with BIO-key
Facebook – Corporate: LinkedIn – Corporate: X – Corporate: X – Investors: StockTwits:	https://www.facebook.com/BIOkeyInternational/ https://www.linkedin.com/company/bio-key-international @BIOkeyIntl @BIO_keyIR BIO_keyIR

Investor Contacts
William Jones, David Collins
Catalyst IR
BKYI@catalyst-ir.com
212-924-9800

FAQ

When is BIO-key's (BKYI) Q2 2025 earnings call?

BIO-key's Q2 2025 earnings call is scheduled for Wednesday, August 13th, 2025 at 10:00 AM ET. The financial results will be released before market open.

How can investors access BIO-key's (BKYI) Q2 2025 earnings call?

Investors can access the call through U.S. dial-in (1-877-418-5460), international dial-in (1-412-717-9594), or via webcast. A replay will be available for 3 months.

Who will lead BIO-key's (BKYI) Q2 2025 earnings call?

The call will be led by Chairman & CEO Mike DePasquale and CFO Cecilia Welch, and will include a Q&A session.

What does BIO-key International (BKYI) specialize in?

BIO-key specializes in Identity and Access Management solutions featuring passwordless, phoneless, and tokenless Identity-Bound Biometric authentication for workforce and customer use.